blood research article

Genomic testing for germline predisposition to hematologic malignancies

• Sang Mee Hwang

The role of next-generation sequencing in hematologic malignancies

• Young-Uk Cho

Acute erythroid leukemia leading to the diagnosis of Schwachman-Diamond syndrome

• Bernhard Strasser
• Sebastian Mustafa
• Alexander Haushofer

Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis

• Imen Frikha
• Moez Elloumi

Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)

• Doaa Mohamed El Demerdash
• Maha Mohamed Saber
• Mohamed Abdelkader Morad

Gaucher or pseudo-Gaucher cells

• Gurpreet Kaur
• Ankur Ahuja

Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia

• Arihant Jain
• Aditya Jandial
• Pankaj Malhotra

Peripheral T-cell lymphoma, NOS in bone marrow and heart

• Hye Won Lee
• Ja Young Lee

Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis

• Saba Manoochehrabadi
• Morteza Talebi
• Mohammad Ahmadvand

Real-world incidence and risk factors of bortezomib-related cardiovascular adverse events in patients with multiple myeloma

• Jonghyun Jeong
• Ju‑Yeun Lee

Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level

• Naree Warnnissorn
• Nonglak Kanitsap
• Suporn Chuncharunee

Genomic technologies for detecting structural variations in hematologic malignancies

• Find a journal
• Publish with us
• Track your research

Advertisement

Issue Highlights

• IFNGR not CSF1R targeting alleviates CNS cGVHD
• TF-FVIIa-PAR2 signaling in pulmonary inflammation
• Registry-based contemporary data for etoposide for pHLH
• BCMA-specific induced pluripotent stem cells
• Pretransfusion Hb in transfusion-dependent thalassemia
• Perspective: arterio-occlusive events with TKI in CML
• Spotlight: pyruvate kinase activators and sickle cell disease

Featured Content

How PAR2 signaling drives thrombo-inflammation; pretransfusion hemoglobin levels linked to survival in beta-thalassemia; etoposide is better than its reputation in primary HLH

Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling

Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice

Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma

Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease

Affiliations.

• Current Issue
• First edition
• Collections
• Submit to Blood
• About Blood
• Subscriptions
• Public Access
• Permissions
• Blood Classifieds
• Advertising in Blood
• Terms and Conditions

American Society of Hematology

• 2021 L Street NW, Suite 900
• Washington, DC 20036
• TEL +1 202-776-0544
• FAX +1 202-776-0545

ASH Publications

• Blood Advances
• Hematology, ASH Education Program
• ASH Clinical News
• The Hematologist
• Publications
• Privacy Policy
• Cookie Policy
• Terms of Use

This Feature Is Available To Subscribers Only

Sign In or Create an Account